Icon

AZITHROMYCIN (nda050809)- (EQ 500MG BASE/VIAL,EQ 2.5GM BASE/VIAL)

AZITHROMYCIN TEVA PARENTERAL
EQ 500MG BASE/VIAL,EQ 2.5GM BASE/VIAL
No Yes
Expired Expired
None None
None No
Azithromycin for injection is indicated for the treatment of patients with infections caused by susceptible strains of the designated microorganisms in the conditions listed below: *Community-acquired pneumonia due to Chlamydia pneumoniae, Haemophilus influenzae, Legionella pneumophila, Moraxella catarrhalis, Mycoplasma pneumoniae, Staphylococcus aureus, or Streptococcus pneumoniae in patients who require initial intravenous therapy. *Pelvic inflammatory disease due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Mycoplasma hominis in patients who require initial intravenous therapy. If anaerobic microorganisms are suspected of contributing to the infection, an antimicrobial agent with anaerobic activity should be administered in combination with azithromycin.
0 0 0
Total Other Developers 31
Drugs with Suitability No
EQ 500MG BASE/VIAL ** ** - - -
EQ 2.5GM BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.